Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Tfh cell subset biomarkers and inflammatory markers are associated with frailty status and frailty subtypes in the community-dwelling older population: a cross-sectional study.

Yin MJ, Xiong YZ, Xu XJ, Huang LF, Zhang Y, Wang XJ, Xiu LC, Huang JX, Lian TY, Liang DM, Zen JM, Ni JD.

Aging (Albany NY). 2020 Feb 8;12(3):2952-2973. doi: 10.18632/aging.102789. Epub 2020 Feb 8.

2.

Development of frailty subtypes and their associated risk factors among the community-dwelling elderly population.

Zhang Y, Xu XJ, Lian TY, Huang LF, Zeng JM, Liang DM, Yin MJ, Huang JX, Xiu LC, Yu ZW, Li YL, Mao C, Ni JD.

Aging (Albany NY). 2020 Jan 16;12(2):1128-1140. doi: 10.18632/aging.102671. Epub 2020 Jan 16.

3.

Effect of traditional Chinese medicine compounds on rumen fermentation, methanogenesis and microbial flora in vitro.

Wang SP, Wang WJ, Tan ZL, Liu GW, Zhou CF, Yin MJ.

Anim Nutr. 2019 Jun;5(2):185-190. doi: 10.1016/j.aninu.2018.09.004. Epub 2018 Oct 25.

4.

Precise Micropatterning of a Porous Poly(ionic liquid) via Maskless Photolithography for High-Performance Nonenzymatic H2O2 Sensing.

Yin MJ, Zhao Q, Wu J, Seefeldt K, Yuan J.

ACS Nano. 2018 Dec 26;12(12):12551-12557. doi: 10.1021/acsnano.8b07069. Epub 2018 Dec 10.

PMID:
30512935
5.

Solution-Processed Bilayer Dielectrics for Flexible Low-Voltage Organic Field-Effect Transistors in Pressure-Sensing Applications.

Yin Z, Yin MJ, Liu Z, Zhang Y, Zhang AP, Zheng Q.

Adv Sci (Weinh). 2018 Jul 11;5(9):1701041. doi: 10.1002/advs.201701041. eCollection 2018 Sep.

6.

Low- Versus High-Risk Rectal Cancer Based on MRI Features: Outcomes in Patients Treated Without Neoadjuvant Chemoradiotherapy.

Jia XX, Wang Y, Cheng J, Yao X, Yin MJ, Zhou J, Ye YJ.

AJR Am J Roentgenol. 2018 Aug;211(2):327-334. doi: 10.2214/AJR.17.18980. Epub 2018 Jun 21.

PMID:
29927331
7.

Retraction notice to "A novel class of specific Hsp90 small molecule inhibitors demonstrate in vitro and in vivo anti-tumor activity in human melanoma cells".

Mehta PP, Kung PP, Yamazaki S, Walls M, Shen A, Nguyen L, Gehring MR, Los G, Smeal T, Yin MJ.

Cancer Lett. 2018 May 28;422:132. doi: 10.1016/j.canlet.2018.03.019. No abstract available.

PMID:
29579439
8.

Corrigendum re: "Suppression of Heat Shock Protein 27 Using OGX-427 Induces Endoplasmic Reticulum Stress and Potentiates Heat Shock Protein 90 Inhibitors to Delay Castrate-resistant Prostate Cancer" [Eur Urol 2014;66:145-55].

Lamoureux F, Thomas C, Yin MJ, Fazli L, Zoubeidi A, Gleave ME.

Eur Urol. 2016 Jul;70(1):e27-e28. doi: 10.1016/j.eururo.2016.03.014. Epub 2016 Mar 31. No abstract available.

PMID:
27302299
9.

Optical fiber LPG biosensor integrated microfluidic chip for ultrasensitive glucose detection.

Yin MJ, Huang B, Gao S, Zhang AP, Ye X.

Biomed Opt Express. 2016 Apr 28;7(5):2067-77. doi: 10.1364/BOE.7.002067. eCollection 2016 May 1.

10.

[Research of chemotaxis response of Botrytis cinerea and Alternaria panax on total ginsenosides].

Chi K, Xu YH, Lei FJ, Yin MJ, Wang Z, Zhang AH, Zhang LX.

Zhongguo Zhong Yao Za Zhi. 2015 Oct;40(19):3742-7. Chinese.

PMID:
26975095
11.

Discovery of 1-{(3R,4R)-3-[({5-Chloro-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a Potent, WT Sparing, Irreversible Inhibitor of T790M-Containing EGFR Mutants.

Cheng H, Nair SK, Murray BW, Almaden C, Bailey S, Baxi S, Behenna D, Cho-Schultz S, Dalvie D, Dinh DM, Edwards MP, Feng JL, Ferre RA, Gajiwala KS, Hemkens MD, Jackson-Fisher A, Jalaie M, Johnson TO, Kania RS, Kephart S, Lafontaine J, Lunney B, Liu KK, Liu Z, Matthews J, Nagata A, Niessen S, Ornelas MA, Orr ST, Pairish M, Planken S, Ren S, Richter D, Ryan K, Sach N, Shen H, Smeal T, Solowiej J, Sutton S, Tran K, Tseng E, Vernier W, Walls M, Wang S, Weinrich SL, Xin S, Xu H, Yin MJ, Zientek M, Zhou R, Kath JC.

J Med Chem. 2016 Mar 10;59(5):2005-24. doi: 10.1021/acs.jmedchem.5b01633. Epub 2016 Jan 28.

PMID:
26756222
12.

Rapid 3D Patterning of Poly(acrylic acid) Ionic Hydrogel for Miniature pH Sensors.

Yin MJ, Yao M, Gao S, Zhang AP, Tam HY, Wai PK.

Adv Mater. 2016 Feb 17;28(7):1394-9. doi: 10.1002/adma.201504021. Epub 2015 Dec 8.

PMID:
26643765
13.

GALNT7, a target of miR-494, participates in the oncogenesis of nasopharyngeal carcinoma.

Nie GH, Luo L, Duan HF, Li XQ, Yin MJ, Li Z, Zhang W.

Tumour Biol. 2016 Apr;37(4):4559-67. doi: 10.1007/s13277-015-4281-6. Epub 2015 Oct 27.

PMID:
26503214
14.

Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancer.

Lamoureux F, Thomas C, Yin MJ, Fazli L, Zoubeidi A, Gleave ME.

Eur Urol. 2014 Jul;66(1):145-55. doi: 10.1016/j.eururo.2013.12.019. Epub 2013 Dec 29. Erratum in: Eur Urol. 2016 Jul;70(1):e27-e28.

15.

Hyperexcitability to electrical stimulation and accelerated muscle fatiguability of taut bands in rats.

Wang YH, Yin MJ, Fan ZZ, Arendt-Nielsen L, Ge HY, Yue SW.

Acupunct Med. 2014 Apr;32(2):172-7. doi: 10.1136/acupmed-2013-010452. Epub 2013 Dec 6.

PMID:
24316508
16.

miR-122 regulates tumorigenesis in hepatocellular carcinoma by targeting AKT3.

Nassirpour R, Mehta PP, Yin MJ.

PLoS One. 2013 Nov 7;8(11):e79655. doi: 10.1371/journal.pone.0079655. eCollection 2013. Retraction in: PLoS One. 2017 Sep 8;12 (9):e0184778.

17.

Targeting small cell lung cancer harboring PIK3CA mutation with a selective oral PI3K inhibitor PF-4989216.

Walls M, Baxi SM, Mehta PP, Liu KK, Zhu J, Estrella H, Li C, Zientek M, Zong Q, Smeal T, Yin MJ.

Clin Cancer Res. 2014 Feb 1;20(3):631-43. doi: 10.1158/1078-0432.CCR-13-1663. Epub 2013 Nov 15. Retraction in: Clin Cancer Res. 2017 Aug 1;23 (15):4523.

18.

miR-221 promotes tumorigenesis in human triple negative breast cancer cells.

Nassirpour R, Mehta PP, Baxi SM, Yin MJ.

PLoS One. 2013 Apr 24;8(4):e62170. doi: 10.1371/journal.pone.0062170. Print 2013. Retraction in: PLoS One. 2017 Apr 10;12 (4):e0175869.

19.

[Short-term efficacy comparison of complete mesocolic excision and traditional colon cancer resection].

Wang T, Ye YJ, Han YM, Gao ZD, Guo P, Yang XD, Jiang KW, Yin MJ, Wang S.

Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Mar;16(3):264-7. Chinese.

PMID:
23536349
20.

Label-free, disposable fiber-optic biosensors for DNA hybridization detection.

Yin MJ, Wu C, Shao LY, Chan WK, Zhang AP, Lu C, Tam HY.

Analyst. 2013 Apr 7;138(7):1988-94. doi: 10.1039/c3an36791f. Epub 2013 Feb 11.

PMID:
23397583
21.

Fiber optic pH sensor with self-assembled polymer multilayer nanocoatings.

Shao LY, Yin MJ, Tam HY, Albert J.

Sensors (Basel). 2013 Jan 24;13(2):1425-34. doi: 10.3390/s130201425.

22.

Targeting the mTOR pathway in tumor malignancy.

Cheng H, Walls M, Baxi SM, Yin MJ.

Curr Cancer Drug Targets. 2013 Mar;13(3):267-77. Review.

PMID:
23297825
23.

Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design.

Cheng H, Li C, Bailey S, Baxi SM, Goulet L, Guo L, Hoffman J, Jiang Y, Johnson TO, Johnson TW, Knighton DR, Li J, Liu KK, Liu Z, Marx MA, Walls M, Wells PA, Yin MJ, Zhu J, Zientek M.

ACS Med Chem Lett. 2012 Nov 7;4(1):91-7. doi: 10.1021/ml300309h. eCollection 2013 Jan 10.

24.

Targeting 3-phosphoinoside-dependent kinase-1 to inhibit insulin-like growth factor-I induced AKT and p70 S6 kinase activation in breast cancer cells.

Baxi SM, Tan W, Murphy ST, Smeal T, Yin MJ.

PLoS One. 2012;7(10):e48402. doi: 10.1371/journal.pone.0048402. Epub 2012 Oct 31. Retraction in: PLoS One. 2017 Apr 10;12 (4):e0175772.

25.

[Feasibility of complete mesocolic excision in elderly patients with colon cancer].

Gao ZD, Ye YJ, Yang XD, Yin MJ, Liang B, Jiang KW, Xie QW, Qu J, Wang YL, Shen ZL, Guo P, Wang S.

Zhonghua Wei Chang Wai Ke Za Zhi. 2012 Oct;15(10):1023-6. Chinese.

PMID:
23099899
26.

Conformationally-restricted cyclic sulfones as potent and selective mTOR kinase inhibitors.

Liu KK, Bailey S, Dinh DM, Lam H, Li C, Wells PA, Yin MJ, Zou A.

Bioorg Med Chem Lett. 2012 Aug 1;22(15):5114-7. doi: 10.1016/j.bmcl.2012.05.104. Epub 2012 Jun 6.

PMID:
22765900
27.

[Learning curve of complete mesocolic excision for colon cancer].

Guo P, Ye YJ, Jiang KW, Gao ZD, Wang T, Yin MJ, Wang YL, Xie QW, Yang XD, Qu J, Liang B, Shen K, Xie F, Yang HP, Wang S.

Zhonghua Wei Chang Wai Ke Za Zhi. 2012 Jan;15(1):28-31. Chinese.

PMID:
22287346
28.

[Complete mesocolic excision versus traditional radical resection in colon cancer].

Gao ZD, Ye YJ, Wang S, Yang XD, Yin MJ, Liang B, Jiang KW, Xie QW, Guo P.

Zhonghua Wei Chang Wai Ke Za Zhi. 2012 Jan;15(1):19-23. Chinese.

PMID:
22287344
29.

Complications associated with tissue anchor migration after vaginal surgery using the tissue fixation system - a case series.

Atherton MJ, Daborn JP, Tsokos N, Jeffery JT, Yin MJ.

Aust N Z J Obstet Gynaecol. 2012 Feb;52(1):83-6. doi: 10.1111/j.1479-828X.2011.01383.x. Epub 2011 Dec 6.

PMID:
22141331
30.

Highly Selective and Potent Thiophenes as PI3K Inhibitors with Oral Antitumor Activity.

Liu KK, Zhu J, Smith GL, Yin MJ, Bailey S, Chen JH, Hu Q, Huang Q, Li C, Li QJ, Marx MA, Paderes G, Richardson PF, Sach NW, Walls M, Wells PA, Baxi S, Zou A.

ACS Med Chem Lett. 2011 Sep 19;2(11):809-13. doi: 10.1021/ml200126j. eCollection 2011 Nov 10. Erratum in: ACS Med Chem Lett. 2012 Feb 9;3(2):170. Baxi, Sangita [added].

31.

Discovery of novel, potent, and selective inhibitors of 3-phosphoinositide-dependent kinase (PDK1).

Murphy ST, Alton G, Bailey S, Baxi SM, Burke BJ, Chappie TA, Ermolieff J, Ferre R, Greasley S, Hickey M, Humphrey J, Kablaoui N, Kath J, Kazmirski S, Kraus M, Kupchinsky S, Li J, Lingardo L, Marx MA, Richter D, Tanis SP, Tran K, Vernier W, Xie Z, Yin MJ, Yu XH.

J Med Chem. 2011 Dec 22;54(24):8490-500. doi: 10.1021/jm201019k. Epub 2011 Nov 23.

PMID:
22040023
32.

PF-04691502, a potent and selective oral inhibitor of PI3K and mTOR kinases with antitumor activity.

Yuan J, Mehta PP, Yin MJ, Sun S, Zou A, Chen J, Rafidi K, Feng Z, Nickel J, Engebretsen J, Hallin J, Blasina A, Zhang E, Nguyen L, Sun M, Vogt PK, McHarg A, Cheng H, Christensen JG, Kan JL, Bagrodia S.

Mol Cancer Ther. 2011 Nov;10(11):2189-99. doi: 10.1158/1535-7163.MCT-11-0185. Epub 2011 Jul 12.

33.

Clusterin inhibition using OGX-011 synergistically enhances Hsp90 inhibitor activity by suppressing the heat shock response in castrate-resistant prostate cancer.

Lamoureux F, Thomas C, Yin MJ, Kuruma H, Beraldi E, Fazli L, Zoubeidi A, Gleave ME.

Cancer Res. 2011 Sep 1;71(17):5838-49. doi: 10.1158/0008-5472.CAN-11-0994. Epub 2011 Jul 7.

34.

Effective targeting of triple-negative breast cancer cells by PF-4942847, a novel oral inhibitor of Hsp 90.

Mehta PP, Whalen P, Baxi SM, Kung PP, Yamazaki S, Yin MJ.

Clin Cancer Res. 2011 Aug 15;17(16):5432-42. doi: 10.1158/1078-0432.CCR-11-0592. Epub 2011 Jun 29. Retraction in: Clin Cancer Res. 2017 Jan 15;23 (2):612.

35.

Pharmacokinetic-pharmacodynamic modeling of biomarker response and tumor growth inhibition to an orally available heat shock protein 90 inhibitor in a human tumor xenograft mouse model.

Yamazaki S, Nguyen L, Vekich S, Shen Z, Yin MJ, Mehta PP, Kung PP, Vicini P.

J Pharmacol Exp Ther. 2011 Sep;338(3):964-73. doi: 10.1124/jpet.111.181339. Epub 2011 Jun 16.

PMID:
21680888
36.

Optimization of potent, selective, and orally bioavailable pyrrolodinopyrimidine-containing inhibitors of heat shock protein 90. Identification of development candidate 2-amino-4-{4-chloro-2-[2-(4-fluoro-1H-pyrazol-1-yl)ethoxy]-6-methylphenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxamide.

Zehnder L, Bennett M, Meng J, Huang B, Ninkovic S, Wang F, Braganza J, Tatlock J, Jewell T, Zhou JZ, Burke B, Wang J, Maegley K, Mehta PP, Yin MJ, Gajiwala KS, Hickey MJ, Yamazaki S, Smith E, Kang P, Sistla A, Dovalsantos E, Gehring MR, Kania R, Wythes M, Kung PP.

J Med Chem. 2011 May 12;54(9):3368-85. doi: 10.1021/jm200128m. Epub 2011 Apr 20.

PMID:
21438541
37.

Transplantation of microencapsulated umbilical-cord-blood-derived hepatic-like cells for treatment of hepatic failure.

Zhang FT, Wan HJ, Li MH, Ye J, Yin MJ, Huang CQ, Yu J.

World J Gastroenterol. 2011 Feb 21;17(7):938-45. doi: 10.3748/wjg.v17.i7.938.

38.

A novel HSP90 inhibitor delays castrate-resistant prostate cancer without altering serum PSA levels and inhibits osteoclastogenesis.

Lamoureux F, Thomas C, Yin MJ, Kuruma H, Fazli L, Gleave ME, Zoubeidi A.

Clin Cancer Res. 2011 Apr 15;17(8):2301-13. doi: 10.1158/1078-0432.CCR-10-3077. Epub 2011 Feb 24. Erratum in: Clin Cancer Res. 2011 Jul 15;17(14):4916.

39.

Linking Nek6 to p53-induced senescence.

Yin MJ.

Cell Cycle. 2011 Jan 1;10(1):18. Epub 2011 Jan 1. No abstract available.

PMID:
21200148
40.

RETRACTED: A novel class of specific Hsp90 small molecule inhibitors demonstrate in vitro and in vivo anti-tumor activity in human melanoma cells.

Mehta PP, Kung PP, Yamazaki S, Walls M, Shen A, Nguyen L, Gehring MR, Los G, Smeal T, Yin MJ.

Cancer Lett. 2011 Jan 1;300(1):30-9. doi: 10.1016/j.canlet.2010.09.002. Retraction in: Cancer Lett. 2018 May 28;422:132.

PMID:
20926183
41.

Nek6 mediates human cancer cell transformation and is a potential cancer therapeutic target.

Nassirpour R, Shao L, Flanagan P, Abrams T, Jallal B, Smeal T, Yin MJ.

Mol Cancer Res. 2010 May;8(5):717-28. doi: 10.1158/1541-7786.MCR-09-0291. Epub 2010 Apr 20. Retraction in: Mol Cancer Res. 2017 Mar;15(3):358.

42.

Low-cost high-performance fiber-optic pH sensor based on thin-core fiber modal interferometer.

Gu B, Yin MJ, Zhang AP, Qian JW, He S.

Opt Express. 2009 Dec 7;17(25):22296-302. doi: 10.1364/OE.17.022296.

PMID:
20052152
43.

Dihydroxyphenylisoindoline amides as orally bioavailable inhibitors of the heat shock protein 90 (hsp90) molecular chaperone.

Kung PP, Huang B, Zhang G, Zhou JZ, Wang J, Digits JA, Skaptason J, Yamazaki S, Neul D, Zientek M, Elleraas J, Mehta P, Yin MJ, Hickey MJ, Gajiwala KS, Rodgers C, Davies JF, Gehring MR.

J Med Chem. 2010 Jan 14;53(1):499-503. doi: 10.1021/jm901209q.

PMID:
19908836
44.

Dihydroxylphenyl amides as inhibitors of the Hsp90 molecular chaperone.

Kung PP, Funk L, Meng J, Collins M, Zhou JZ, Johnson MC, Ekker A, Wang J, Mehta P, Yin MJ, Rodgers C, Davies JF 2nd, Bayman E, Smeal T, Maegley KA, Gehring MR.

Bioorg Med Chem Lett. 2008 Dec 1;18(23):6273-8. doi: 10.1016/j.bmcl.2008.09.081. Epub 2008 Sep 26.

PMID:
18929486
45.

[Study on clinicopathological correlations between metabolic syndrome and colorectal carcinoma].

Shen ZL, Wang S, Ye YJ, Yin MJ, Yang XD, Jiang KW, Liu Y.

Zhonghua Wai Ke Za Zhi. 2008 Apr 1;46(7):537-9. Chinese.

PMID:
18785568
46.

[Clinical value of screening hereditary nonpolyposis colorectal cancer in China with protocol recommended by NCCN guidelines].

Shen K, Wang S, Ye YJ, Yin MJ, Yang XD, Xu F, Liang B, Jiang KW, Cui ZR.

Zhonghua Wei Chang Wai Ke Za Zhi. 2008 Jul;11(4):317-21. Chinese.

PMID:
18636350
47.

[Clinicopathological analysis of synchronous hepatic metastases from colorectal cancer].

Ye YJ, Wang S, Wu J, Shen ZL, Yin MJ, Yang XD, Jiang KW, Zhou J.

Zhonghua Wei Chang Wai Ke Za Zhi. 2008 May;11(3):208-12. Chinese.

PMID:
18478460
48.

Impact of postoperative omega-3 fatty acid-supplemented parenteral nutrition on clinical outcomes and immunomodulations in colorectal cancer patients.

Liang B, Wang S, Ye YJ, Yang XD, Wang YL, Qu J, Xie QW, Yin MJ.

World J Gastroenterol. 2008 Apr 21;14(15):2434-9.

49.

[Clinical and pathological features of synchronous double primary cancer in stomach and large intestine].

Shen ZL, Wang S, Ye YJ, Yin MJ, Yang XD, Jiang KW, Shen K.

Zhonghua Yi Xue Za Zhi. 2008 Jan 15;88(3):162-4. Chinese.

PMID:
18361811
50.

[Establishment of animal model for in vitro spermatogenesis by heterotopic grafting of neonatal mouse testis].

Yu J, Ye J, Zhang FT, Wan HJ, Yin MJ, Fang JZ, Gui YT, Cai ZM.

Beijing Da Xue Xue Bao Yi Xue Ban. 2004 Dec;36(6):591-4. Chinese.

Supplemental Content

Support Center